Patrick Cooney
Physician Assistant · New Baltimore, MINPI 1811527682
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by AbbVie at 34.3% of the total. Among physician assistant clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,578 payments — averaging $57.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$31K
- Axsome Therapeutics, Inc.$21K
- Teva Pharmaceuticals USA, Inc.$18K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$3K
- Otsuka America Pharmaceutical, Inc.$3K
- Johnson & Johnson$2K
- plus $13K from 31 others
What the payments were for
- Consulting fees$7,2508%
- Speaking & faculty fees$48,47654%
- Travel & lodging$7,3358%
- Food & beverage$27,21330%
- Education$2950%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$27,658
- Auvelity$19,376
- UZEDY$15,679
- REXULTI$476
- CAPLYTA$462
- Azstarys$263
- INGREZZA$249
- INVEGA SUSTENNA$220
- Wegovy$124
- ABILIFY ASIMTUFII$118
- ABILIFY MAINTENA$118
- QUVIVIQ$107
- Fanapt$106
- INVEGA TRINZA$105
- INVEGA$105
- SPRAVATO$105
How this compares
$90,569 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 64 | $639,473 |
| AustedoDeutetrabenazine | 18 | $136,265 |
| IngrezzaValbenazine Tosylate | 11 | $121,258 |
| AuvelityDextromethorphan Hbr/Bupropion | 28 | $52,365 |
| CaplytaLumateperone Tosylate | 11 | $27,746 |
| VraylarCariprazine Hcl | 13 | $21,230 |
| NuedextaDextromethorphan Hbr/Quinidine | 12 | $19,537 |
| BelsomraSuvorexant | 24 | $17,196 |
| LybalviOlanzapine/Samidorphan Malate | 11 | $16,813 |
| VyvanseLisdexamfetamine Dimesylate | 35 | $13,003 |
| Lurasidone Hcl | 58 | $11,647 |
| Lisdexamfetamine Dimesylate | 33 | $7,251 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 148 | $6,968 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 197 | $4,841 |
| Duloxetine Hcl | 194 | $4,762 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr, Austedo | $18,362 | $775,73882 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $1,871 | $121,25811 claims |
| Axsome Therapeutics, Inc.Auvelity | $20,753 | $52,36528 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $2,749 | $27,74611 claims |
| AbbVieVraylar | $31,072 | $21,23013 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $191 | $19,53712 claims |
| MerckBelsomra | $115 | $17,19624 claims |
| Alkermes, Inc.Lybalvi | $1,014 | $16,81311 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $659 | $13,00335 claims |
| Lilly USA, LLCOlanzapine | $82 | $3,651110 claims |
| Almatica Pharma LLCSertraline Hcl | $275 | $2,167129 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in New Baltimore
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
- Melissa JosephGrand Rapids$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.